Company
Ideaya
Unlocking novel targets to redefine what's possible for people with hard-to-treat cancers
Also known as Ideaya Biosciences
- Business model
- B2B
- Customers
- patients who need them most
- Legal name
- IDEAYA Biosciences
- ideayabio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Ideaya Biosciences uses small molecules as novel personalized cancer therapies, leveraging direct targeting of oncogenic pathways and synthetic lethality – an emerging class of precision medicine targets.
Funding snapshot
- Total raised
- $111MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $94M2018-01-31
Funding rounds
- Round, 2018
- $94M2018-01-31, SEC form D sold, 23 investors
- Round, 2016
- $17.4M2016-03-01, SEC form D sold, 10 investors
Products
- Other
- darovasertib
- Web
- darovasertib
Loading relationship preview